Insulin Masters India Webinar Series

This course features recorded webinars from the American Diabetes Association’s Insulin Masters program, developed specifically for healthcare professionals in India. Through expert-led presentations and practical clinical discussions, learners will gain evidence-based insights into contemporary insulin therapy, including individualized treatment approaches, insulin use in special populations, and strategies for safely integrating insulin with newer treatments. Designed for flexible, self-paced learning, the course provides access to internationally recognized ADA faculty and clinically relevant content tailored to support the effective use of insulin in the Indian healthcare setting.

Overview

Learning Objectives

Summarize current evidence and recommendations for insulin therapy.
Apply individualized approaches to insulin management across diverse patient populations.
Recognize strategies for safe and effective insulin use in complex clinical situations.
Describe the role of insulin in comprehensive diabetes management.
Incorporate clinical considerations relevant to insulin management in India.

Faculty

	Estelle Everett, MD Endocrinologist and Health Services Researcher at UCLA. Specializes in improving care for people with type 1 diabetes, with a focus on health equity and expanding access to diabetes technology in underserved populations. Leads NIH-funded research evaluating advanced insulin delivery systems in diverse clinical settings.
	Rashika Bansal, MD, DABOM Assistant Professor of Endocrinology at Rutgers Robert Wood Johnson Medical School and board-certified obesity medicine specialist. Clinical and research interests include obesity, diabetes, metabolic disorders, and endocrine complications of cancer therapies. Former NIH investigator with expertise in obesity and rare metabolic diseases.
	Viral Shah, MBBS Professor of Medicine and Director of Diabetes Clinical Research at Indiana University School of Medicine. Internationally recognized expert in type 1 diabetes, diabetes technology, and diabetes-related bone health. Principal investigator on numerous landmark clinical trials that have advanced diabetes device innovation and patient care.
	Mary Pat Gallagher, MD Division Director of Pediatric Endocrinology and Diabetes at NYU Grossman School of Medicine and Medical Director of the Pediatric Diabetes Center at Hassenfeld Children's Hospital at NYU Langone. Pediatric endocrinologist specializing in diabetes care and advancing outcomes for children and adolescents living with diabetes.
	Andrew S. Rhinehart, MD, FACP, FACE, CDCES Chief Executive Officer and Chief Scientific & Medical Officer of Sansum Diabetes Research Institute. Recognized leader in diabetes technology, clinical research, and innovation, with extensive experience leading global trials in continuous glucose monitoring and automated insulin delivery. Former Senior Medical Director at Medtronic Diabetes and advocate for advancing diabetes prevention and care worldwide.

Summary

Availability:

On-Demand

Expires on Dec 31, 2027

Cost:

FREE

Credit Offered:

No Credit Offered

Contains:

5 Courses

Create Account